Research Topics
| S KrimskySummaryAffiliation: Tufts University Country: USA Publications
| Collaborators
|
Detail Information
Publications
Science on trial: conflicts of interest jeopardize scientific integrity and public healthSheldon Krimsky
Department of Urban and Environmental Policy and Planning, Tufts University, USA
Genewatch 16:3-6. 2003
Introduction to special issue of Accountability in Research on conflict of interest in scienceSheldon Krimsky
Dept. of Urban and Environmental Policy, 97 Talbot Ave, Medford, MA 02155, USA
Account Res 11:79-81. 2004
Commentary: Corporate philanthropy and conflicts of interest in public healthSheldon Krimsky
Department of Urban and Environmental Policy and Planning, Tufts University, 97 Talbot Avenue, Medford, MA 02155, USA
J Public Health Policy 34:137-9. 2013..Article JPHP.2012.60 available at www.palgrave-journals.com/jphp/, relates to this commentary...
The weight of scientific evidence in policy and lawSheldon Krimsky
Department of Urban and Environmental Policy and Planning, Tufts University, Medford, MA 02155, USA
Am J Public Health 95:S129-36. 2005....
From Asilomar to industrial biotechnology: risks, reductionism and regulationSheldon Krimsky
Department of Urban and Environmental Policy and Planning, Tufts University, Medford, MA 02155, USA
Sci Cult (Lond) 14:309-23. 2005
Testing pesticides in humans: of mice and men divided by tenSheldon Krimsky
Center for the History and Ethics of Public Health, Department of Sociomedical Sciences, Mailman School of Public Health, Columbia University, New York, NY 10032, USA
JAMA 297:2405-7. 2007
An analysis of toxicology and medical journal conflict-of-interest policesSheldon Krimsky
Department of Urban and Environmental Policy and Planning, Tufts University, Medford, Massachusetts 02155, USA
Account Res 16:235-53. 2009..Lack of specificity, high author discretion, and restricted scope were found to be prevalent among COI policies of toxicology and medical journals...
An epistemological inquiry into the endocrine disruptor thesisS Krimsky
Department of Urban and Environmental Policy and Planning, Tufts University, Medford, Massachusetts 02155, USA
Ann N Y Acad Sci 948:130-42. 2001..Reflections on scientific methodology in this field will also help clarify whether endocrine disruptors symbolize a new etiology of chemically induced disease or represent variations of traditional chemical toxicology...
Conflict of interest policies in science and medical journals: editorial practices and author disclosuresS Krimsky
Department of Urban and Environmental Police, Tufts University, Medford, MA 02155 5814, USA
Sci Eng Ethics 7:205-18. 2001....
Financial interest and its disclosure in scientific publicationsS Krimsky
Department of Urban and Environmental Policy, Tufts University, Medford, Mass 02155, USA
JAMA 280:225-6. 1998..The authors believe that the scientific community and the public will be best served by open publication of financial disclosures for readers and reviewers to evaluate...
A conflict of interestSheldon Krimsky
Tufts University, Massachusetts, USA
New Sci 179:21. 2003
Human gene therapy: must we know where to stop before we start?S Krimsky
Department of Urban and Environmental Policy, Tufts University, Medford, MA 02155
Hum Gene Ther 1:171-3. 1990..Each proposal involves a distinction and a rule. There is a dilemma in that the first case involves a well-grounded distinction but a dubious rule, while the second offers a more favored rule, but a fuzzy distinction...
Small gifts, conflicts of interest, and the zero-tolerance threshold in medicineSheldon Krimsky
Tufts University, USA
Am J Bioeth 3:50-2. 2003
When conflict-of-interest is a factor in scientific misconductSheldon Krimsky
Department of Urban and Environmental Policy and Planning, Tufts University, Medford, USA
Med Law 26:447-63. 2007..Thus, lack of transparency to reviewers, journals and readers for conflicts of interest should be considered a form of scientific misconduct...
Editorial policies on financial disclosureMichael F Jacobson
Nat Neurosci 6:1001. 2003
Advice without dissentDavid Michaels
Science 298:703. 2002
For the recordSheldon Krimsky
Nat Genet 30:139-40. 2002
Fraudulent human embryonic stem cell research in South Korea: lessons learnedDavid B Resnik
National Institute of Environmental Health Sciences, National Institutes of Health, Mail Drop NH 06, Box 12233, NIEHS/NIH, Research Triangle Park, NC 27709, USA
Account Res 13:101-9. 2006
Financial ties between DSM-IV panel members and the pharmaceutical industryLisa Cosgrove
University of Massachusetts, Boston, USA
Psychother Psychosom 75:154-60. 2006..Full disclosure by DSM panel members of their financial relationships with for-profit entities that manufacture drugs used in the treatment of mental illness is recommended...
Emergence of a scientific and commercial research and development infrastructure for human gene therapyChristine Crofts
Department of Sociology, Boston College, Chestnut Hill, MA 02467, USA
Hum Gene Ther 16:169-77. 2005..Despite setbacks and few documented successes, the subfield of human gene therapy continues to serve as an influential clinical paradigm for the treatment of inherited and noninherited diseases...
Daniel Callahan and health's priceSheldon Krimsky
Health Aff (Millwood) 23:288. 2004
